{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:34:34Z","timestamp":1794339274346,"version":"4.9.0"},"reference-count":80,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Delivery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1080\/10717544.2021.1937383","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T10:52:46Z","timestamp":1623495166000},"page":"1188-1203","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":38,"title":["Repurposing ibuprofen-loaded microemulsion for the management of Alzheimer\u2019s disease: evidence of potential intranasal brain targeting"],"prefix":"10.1080","volume":"28","author":[{"given":"Ming Ming","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics &amp; Pharmaceutical Technology, Pharos University in Alexandria, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Ismail Khamis","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics &amp; Pharmaceutical Technology, Pharos University in Alexandria, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M. A.","family":"Nasra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Hassan","family":"El-Kamel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph3061949"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1201\/9781420089608.ch9"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00408-1"},{"key":"e_1_3_2_5_1","unstructured":"Alzheimer\u2019s Association Medications for Memory Loss | Alzheimer\u2019s Association. (2019). https:\/\/www.alz.org\/alzheimers-dementia\/treatments\/medications-for-memory [last accessed 7 May 2020]."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.01.010"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000345791"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119148"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000321044"},{"key":"e_1_3_2_10_1","volume-title":"Medical physiology: a cellular and molecular approach","author":"Boron WF","year":"2016","unstructured":"Boron WF, Boulpaep EL. (2016). Medical physiology: a cellular and molecular approach. 3rd ed. Philadelphia (PA): Elsevier. https:\/\/www.worldcat.org\/title\/medical-physiology-a-cellular-and-molecular-approach\/oclc\/190860094 [last accessed 20 Feb 2021].","edition":"3"},{"key":"e_1_3_2_11_1","volume-title":"British pharmacopoeia 2013","author":"British Pharmacopoeia Commission.","year":"2013","unstructured":"British Pharmacopoeia Commission. (2013). British pharmacopoeia 2013. London: Stationery Office."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.32388\/yokp53"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152710791011991"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0207-9"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5045-09.2010"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.02.014"},{"key":"e_1_3_2_18_1","unstructured":"Dow Chemicals Propylene Glycol. (2014). http:\/\/msdssearch.dow.com\/PublishedLiteratureDOWCOM\/dh_0917\/0901b8038091745a.pdf?filepath=propyleneglycol\/pdfs\/noreg\/117-17105.pdf&fromPage=GetDoc."},{"key":"e_1_3_2_19_1","unstructured":"Eisai and Biogen. (2019). Discontinue phase III clinical studies of BACE inhibitor Elenbecestat in early Alzheimer\u2019s disease [Press Release] 1\u20133. https:\/\/www.prnewswire.com\/news-releases\/eisai-and-biogen-to-discontinue-phase-iii-clinical-studies-of-bace-inhibitor-elenbecestat-in-early-alzheimers-disease-300917734.html [last accessed 30 Apr 2020]."},{"key":"e_1_3_2_20_1","first-page":"200","article-title":"Localization and distribution of human olfactory mucosa in the nasal cavities]","volume":"26","author":"Escada P.","year":"2013","unstructured":"Escada P. (2013). [Localization and distribution of human olfactory mucosa in the nasal cavities]. Acta Med Port 26:200\u20137.","journal-title":"Acta Med Port"},{"key":"e_1_3_2_21_1","unstructured":"FDA GRAS Substances (SCOGS) Database. (2018). https:\/\/www.accessdata.fda.gov\/scripts\/fdcc\/?set=SCOGS [last accessed 11 May 2020]."},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4353-06.2007"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10216"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2018.01.123"},{"key":"e_1_3_2_25_1","first-page":"14","article-title":"Neuroinflammation in Alzheimer\u2019s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation","volume":"21","author":"Hensley K.","year":"2010","unstructured":"Hensley K. (2010). Neuroinflammation in Alzheimer\u2019s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimer\u2019s Dis 21:14.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(02)00363-2"},{"key":"e_1_3_2_27_1","first-page":"1","article-title":"Are NSAIDs useful to treat Alzheimer\u2019s disease or mild cognitive impairment?","volume":"2","author":"Imbimbo BP","year":"2010","unstructured":"Imbimbo BP, Solfrizzi V, Panza F. (2010). Are NSAIDs useful to treat Alzheimer\u2019s disease or mild cognitive impairment? Front Aging Neurosci 2:1\u201314.","journal-title":"Front Aging Neurosci"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010178"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9440-x"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12808"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21190"},{"key":"e_1_3_2_32_1","volume-title":"Histology, respiratory epithelium","author":"Kia\u2019I N","year":"2019","unstructured":"Kia\u2019I N, Bajaj T. (2019). Histology, respiratory epithelium. Treasure Island (FL): StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31082105 [last accessed 6 March 2021]."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(00)00614-1"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(02)00629-2"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00103-4"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2012.09.018"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/02652048.2018.1559245"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(02)00029-7"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2013.838014"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2018.2169"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152710791012071"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/la00058a046"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170706"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-009-9356-5"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.02.023"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph3061812"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-8686(98)00063-3"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2011.627871"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-012-9762-y"},{"key":"e_1_3_2_51_1","first-page":"20","article-title":"Formulation and evaluation of microemulsions-based drug delivery system for intranasal administration of olanzapine","volume":"7","author":"Patel RB","year":"2013","unstructured":"Patel RB, Mrunali Patel BR, Kashyap Bhatt BK, Bharat Patel BG. (2013). Formulation and evaluation of microemulsions-based drug delivery system for intranasal administration of olanzapine. Int J Biomed Pharm Sci 7:20\u20137.","journal-title":"Int J Biomed Pharm Sci"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bfopcu.2013.07.002"},{"key":"e_1_3_2_53_1","volume-title":"World Alzheimer report 2018. The state of the art of dementia research: new frontiers","author":"Patterson C.","year":"2018","unstructured":"Patterson C. (2018). World Alzheimer report 2018. The state of the art of dementia research: new frontiers. London (UK): Alzheimer\u2019s Disease International."},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200204000-00002"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/930356"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1021\/la00093a018"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.proche.2015.12.031"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2016.12.013"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200121010-00010"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.03.037"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1208\/pt0802028"},{"key":"e_1_3_2_62_1","volume-title":"Handbook of pharmaceutical excipients","author":"Sheskey PJ","year":"2020","unstructured":"Sheskey PJ, Hancock BC, Moss GP, Goldfarb DJ. (2020). Handbook of pharmaceutical excipients. 9th ed. London: Pharmaceutical Press.","edition":"9"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200218666170607101622"},{"key":"e_1_3_2_64_1","first-page":"22","article-title":"Nasal cavity, a promising transmucosal platform for drug delivery and research approaches from nasal to brain targetting","volume":"2","author":"Singh AK","year":"2012","unstructured":"Singh AK, Singh A, Madhv NS. (2012). Nasal cavity, a promising transmucosal platform for drug delivery and research approaches from nasal to brain targetting. J Drug Deliv Ther 2:22.","journal-title":"J Drug Deliv Ther"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.12.019"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8955-3_2"},{"key":"e_1_3_2_67_1","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1201\/b19309","volume-title":"Encyclopedia of pharmaceutical technology","author":"Swarbrick J.","year":"2013","unstructured":"Swarbrick J. (2013). Emulsions and microemulsions. In: Encyclopedia of pharmaceutical technology. 3rd ed. Boca Raton (FL): Taylor & Francis, 1548.","edition":"3"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000284596.95156.48"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11743-014-1618-x"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2012.727003"},{"key":"e_1_3_2_71_1","first-page":"600","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner PV","year":"2011","unstructured":"Turner PV, Brabb T, Pekow C, Vasbinder MA. (2011). Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50:600\u201313.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"e_1_3_2_72_1","first-page":"3078","article-title":"Repurposing drugs for management of Alzheimer disease","volume":"12","author":"Venkatachalam S","year":"2019","unstructured":"Venkatachalam S, Jaiswal A, De A, Vijayakumar RK. (2019). Repurposing drugs for management of Alzheimer disease. Res J Pharm Technol 12:3078\u201388.","journal-title":"Res J Pharm Technol"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2011.633262"},{"key":"e_1_3_2_74_1","first-page":"497","article-title":"Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain \u2014 current development","volume":"11","author":"Wen MM.","year":"2011","unstructured":"Wen MM. (2011). Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain \u2014 current development. Discov Med 11:497\u2013503.","journal-title":"Discov Med"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1039\/tf9484400376"},{"key":"e_1_3_2_76_1","first-page":"119","article-title":"World health organization model list of essential medicines","author":"World Health Organization (WHO)","year":"2019","unstructured":"World Health Organization (WHO) (2019). World health organization model list of essential medicines. Ment Holist Heal Some Int Perspect 119\u201334.","journal-title":"Ment Holist Heal Some Int Perspect"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.54.48"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9185-1"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2012.687378"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1090154"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.3892\/br.2020.1347"}],"container-title":["Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2021.1937383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T15:52:34Z","timestamp":1724169154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10717544.2021.1937383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1080\/10717544.2021.1937383"],"URL":"https:\/\/doi.org\/10.1080\/10717544.2021.1937383","relation":{},"ISSN":["1071-7544","1521-0464"],"issn-type":[{"value":"1071-7544","type":"print"},{"value":"1521-0464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}